Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney‐Transplant and Hematopoietic Cell Transplant Recipients
In this study, we longitudinally tracked the in vivo persistence of adoptively transferred BKV-CTLs and demonstrated their sustained functional activity. This therapy could be promising in KT and SCT patients with recent-onset BK-virus viremia.
Authors
- Katayoun Rezvani (ORCID: https://orcid.org/0000-0002-9599-2246)
- Nadima Uprety (ORCID: https://orcid.org/0000-0003-4379-6208)
- Glorette Abueg
- Rafet Başar (ORCID: https://orcid.org/0000-0003-4713-0454)
- Francia Reyes Silva
- Rejeena Shrestha (ORCID: https://orcid.org/0000-0001-7642-6735)
- Amanda Olson (ORCID: https://orcid.org/0000-0002-1669-0355)
- Indresh Kaur
- Valda D. Page
- Linda Moore
- Ye Ethan Li
- Osama A. Gaber
- Richard E. Champlin
- Roy F. Chemaly
- Melihate Sylejmani
- Pinaki Banerjee
- Dimitrios P. Kontoyiannis
- Elizabeth J. Shpall
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Methodist Hospital (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1111/tid.70178
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- University of Texas MD Anderson Cancer Center